Naltrexone hydrochloride 50 MG Oral Tablet — RxCUI 1483744
RxNorm drug concept · Semantic clinical drug
RxCUI 1483744
Semantic clinical drug · SCD
● Current RxNorm concept 42 FDA products
88 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1483744
Official nameNaltrexone hydrochloride 50 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnaltrexone HCl 50 MG Oral Tablet
FDA products mapped42
Package NDCs mapped88
Reported Medicaid activity (SDUD)817,574 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Naltrexone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes — this is really important. You need to be completely free of opioids, including tramadol, for at least 7 to 10 days before your first dose or injection. If you start too soon,...
- Do I have to stop my pain pills before starting naltrexone?
- No. Naltrexone has no opioid-like effect on its own — it won't make you feel high or sedated. And if you're opioid-free when you start it, you won't feel withdrawal either. It's on...
- Will naltrexone make me feel high or cause withdrawal if I'm not on opioids?
🕸️ Concept Web — How Naltrexone hydrochloride 50 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Naltrexone hydrochloride 50 MG Oral Tablet
RxCUI 1483744 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Naltrexone
7243IN -
Naltrexone hydrochloride
105069PIN
-
Naltrexone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
ReVia
152092BN
-
ReVia
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Naltrexone Oral Tablet
372990SCDF -
Naltrexone hydrochloride Oral Tablet
2645695SCDFP -
Naltrexone Oral Product
1156982SCDG -
Naltrexone Pill
1156983SCDG -
Naltrexone hydrochloride Oral Product
2662176SCDGP -
Naltrexone hydrochloride Pill
2662632SCDGP -
Naltrexone Oral Tablet [ReVia]
368791SBDF -
Naltrexone hydrochloride Oral Tablet [ReVia]
2658172SBDFP - +5 more in this family
-
Naltrexone Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Naltrexone hydrochloride 50 MG
1483743SCDC -
Naltrexone hydrochloride 50 MG Oral Tablet [ReVia]
1483746SBD -
Naltrexone hydrochloride 50 MG [ReVia]
1483745SBDC
-
Naltrexone hydrochloride 50 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Naltrexone hydrochloride 50 MG
SCDC · 1483743 -
Naltrexone Oral Tablet
SCDF · 372990 -
Naltrexone hydrochloride Oral Tablet
SCDFP · 2645695 -
Naltrexone Oral Product
SCDG · 1156982 -
Naltrexone Pill
SCDG · 1156983 -
Naltrexone hydrochloride Oral Product
SCDGP · 2662176 -
Naltrexone hydrochloride Pill
SCDGP · 2662632
Brand-Name Concepts
-
Naltrexone hydrochloride 50 MG Oral Tablet [ReVia]
SBD · 1483746 -
Naltrexone hydrochloride 50 MG [ReVia]
SBDC · 1483745 -
Naltrexone Oral Tablet [ReVia]
SBDF · 368791 -
Naltrexone hydrochloride Oral Tablet [ReVia]
SBDFP · 2658172 -
ReVia Oral Product
SBDG · 1178314 -
ReVia Pill
SBDG · 1178315 -
ReVia
BN · 152092
📦 FDA Products & Package NDCs
42 products · 88 package NDCs
88 package NDCs map to RxCUI 1483744 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71335-2062-01 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-2062-1) | NALTREXONE HYDROCHLORIDE | Bryant Ranch Prepack | 2022-03-21 |
| 71335-2062-02 | 90 TABLET, FILM COATED in 1 BOTTLE (71335-2062-2) | NALTREXONE HYDROCHLORIDE | Bryant Ranch Prepack | 2022-03-21 |
| 71335-2062-03 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-2062-3) | NALTREXONE HYDROCHLORIDE | Bryant Ranch Prepack | 2022-03-21 |
| 71335-2062-04 | 45 TABLET, FILM COATED in 1 BOTTLE (71335-2062-4) | NALTREXONE HYDROCHLORIDE | Bryant Ranch Prepack | 2022-03-21 |
| 71335-2062-05 | 120 TABLET, FILM COATED in 1 BOTTLE (71335-2062-5) | NALTREXONE HYDROCHLORIDE | Bryant Ranch Prepack | 2022-03-21 |
| 71335-2062-06 | 15 TABLET, FILM COATED in 1 BOTTLE (71335-2062-6) | NALTREXONE HYDROCHLORIDE | Bryant Ranch Prepack | 2022-03-21 |
| 71335-2419-01 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-2419-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-11-12 |
| 71335-2419-02 | 90 TABLET, FILM COATED in 1 BOTTLE (71335-2419-2) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-11-12 |
| 71335-2419-03 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-2419-3) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-11-12 |
| 71335-2419-04 | 45 TABLET, FILM COATED in 1 BOTTLE (71335-2419-4) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-11-12 |
| 71335-2419-05 | 120 TABLET, FILM COATED in 1 BOTTLE (71335-2419-5) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-11-12 |
| 71335-2419-06 | 15 TABLET, FILM COATED in 1 BOTTLE (71335-2419-6) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-11-12 |
| 71335-2419-07 | 100 TABLET, FILM COATED in 1 BOTTLE (71335-2419-7) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-11-12 |
| 71335-2480-01 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-2480-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-08-27 |
| 71335-2481-01 | 100 TABLET, FILM COATED in 1 BOTTLE (71335-2481-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-08-27 |
| 71335-2743-01 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-2743-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2025-07-29 |
| 71335-2987-01 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-2987-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-02-15 |
| 71335-3011-01 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-3011-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2025-11-18 |
| 71335-3012-01 | 100 TABLET, FILM COATED in 1 BOTTLE (71335-3012-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2025-11-18 |
| 71335-3039-01 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-3039-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2025-12-03 |
| 71335-3040-01 | 100 TABLET, FILM COATED in 1 BOTTLE (71335-3040-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2025-12-03 |
| 71335-3104-01 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-3104-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2026-03-16 |
| 71335-3104-02 | 90 TABLET, FILM COATED in 1 BOTTLE (71335-3104-2) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2026-03-16 |
| 71335-3104-03 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-3104-3) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2026-03-16 |
| 71335-3104-04 | 45 TABLET, FILM COATED in 1 BOTTLE (71335-3104-4) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2026-03-16 |
| 71335-3104-05 | 120 TABLET, FILM COATED in 1 BOTTLE (71335-3104-5) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2026-03-16 |
| 71335-3104-06 | 15 TABLET, FILM COATED in 1 BOTTLE (71335-3104-6) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2026-03-16 |
| 71335-3104-07 | 100 TABLET, FILM COATED in 1 BOTTLE (71335-3104-7) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2026-03-16 |
| 71610-0919-31 | 600 TABLET, FILM COATED in 1 BOTTLE (71610-919-31) | NALTREXONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 2025-07-01 |
| 71610-0964-31 | 600 TABLET, FILM COATED in 1 BOTTLE (71610-964-31) | NALTREXONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 2025-11-13 |
| 72162-1566-01 | 100 TABLET, FILM COATED in 1 BOTTLE (72162-1566-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2023-09-12 |
| 72162-1566-03 | 30 TABLET, FILM COATED in 1 BOTTLE (72162-1566-3) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2023-09-12 |
| 72162-2154-03 | 30 TABLET, FILM COATED in 1 BOTTLE (72162-2154-3) | NALTREXONE HYDROCHLORIDE | Bryant Ranch Prepack | 2023-12-07 |
| 72162-2311-01 | 100 TABLET, FILM COATED in 1 BOTTLE (72162-2311-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-02-15 |
| 72162-2311-03 | 30 TABLET, FILM COATED in 1 BOTTLE (72162-2311-3) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2024-02-15 |
| 72162-2529-01 | 100 TABLET, FILM COATED in 1 BOTTLE (72162-2529-1) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2025-09-03 |
| 72162-2529-03 | 30 TABLET, FILM COATED in 1 BOTTLE (72162-2529-3) | Naltrexone Hydrochloride | Bryant Ranch Prepack | 2025-09-03 |
| 82804-0199-30 | 30 TABLET, FILM COATED in 1 BOTTLE (82804-199-30) | NALTREXONE HYDROCHLORIDE | Proficient Rx LP | 2025-02-21 |
Observed labelers:
Bryant Ranch Prepack (49) ·
Precision Dose Inc. (5) ·
Sun Pharmaceutical Industries, Inc. (4) ·
Aphena Pharma Solutions - Tennessee, LLC (3) ·
Chartwell RX, LLC (3) ·
A-S Medication Solutions (2)
· +14 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$1.1910
Range $1.1910–$1.1910
· middle 50% $1.1910–$1.1910
· 19 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.